GlassScriptPhysician profile
Michael A Krafczyk
NPI 1942264411
$1,571.10
in general payments reported to CMS, 2019-2025
14 companies · $316 in 2025
The $316 reported for 2025 was more than what 76% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $75.75 · 2021: $134 · 2022: $250 · 2023: $267 · 2024: $242 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $674.46 | 2019-2025 | Euflexxa |
| Bioventus LLC | $228.41 | 2019-2023 | Durolane, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $147.62 | 2019-2025 | Monovisc, Orthovisc |
| Ermi LLC | $78.16 | 2024-2025 | |
| Arteriocyte Medical Systems, INC. | $77.20 | 2022 | |
| Novus Surgical Solutions LLC | $70.10 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $66.58 | 2025 | |
| Electronic Waveform Lab, INC. | $65.16 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $49.19 | 2022 | |
| Zimmer Biomet Holdings, INC. | $29.87 | 2019-2022 | |
| Radius Health, INC. | $29.44 | 2019-2022 | |
| Novus Surgical Consultants | $20.31 | 2024 | |
| Pacira Therapeutics, INC. | $19.32 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Krafczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.